About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Active Not RecruitingNANCT07009483

Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient Outcomes

In a previous part of this study, we created educational modules about the psychodermatology of inflammatory skin conditions, with a particular emphasis on atopic dermatitis, for patients. These modul...

Lead sponsor: University of Alberta•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Alberta

Age

4 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. New diagnosis or follow-up for previous diagnosis of Atopic Dermatitis.
•2. Reliable internet access to be able to access the e-modules.
•3. Able to speak English at a level required to understand the content of this study.
•4. Child participants will be included in this study contingent on the consent of their guardian/caregiver(s).
•5. Age range of eligible participants: Age 4 years and older.

Exclusion Criteria

•1. Does not have a new diagnosis or follow-up for previous diagnosis of Atopic Dermatitis.
•2. Unable to access and/or navigate e-modules with reasonable support/instruction.
•3. Unable to speak English at a level required to understand the content of this study.
•4. Unable to provide informed consent.
•5. Less than 4 years of age.

Related studies

RECRUITINGPhase 2

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

NCT07298395 · Atopic Dermatitis (AD)

RECRUITINGPhase 1

The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis

NCT06928246 · Atopic Dermatitis (AD)

Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis

NCT07316465 · Atopic Dermatitis (AD), Autoantibody, and more

RECRUITINGPhase 1

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

NCT06982352 · Atopic Dermatitis (AD), Psoriasis (PsO)

RECRUITINGPhase 1

A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis

NCT07235384 · Atopic Dermatitis (AD)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 27, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhaseNA

Enrollment42

Start dateJun 2025

Last updatedAug 27, 2025

Condition

Atopic Dermatitis (AD)

Locations shown

Rao Dermatology

Edmonton, Alberta

Kaye Edmonton Clinic

Edmonton, Alberta

Stollery Children's Hospital

Edmonton, Alberta

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 27, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions